172 related articles for article (PubMed ID: 34978330)
21. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory bowel disease genetics: Nod2.
Cho JH; Abraham C
Annu Rev Med; 2007; 58():401-16. PubMed ID: 16987083
[TBL] [Abstract][Full Text] [Related]
23.
Schäffler H; Rohde M; Rohde S; Huth A; Gittel N; Hollborn H; Koczan D; Glass Ä; Lamprecht G; Jaster R
World J Gastroenterol; 2018 Mar; 24(11):1196-1205. PubMed ID: 29568200
[TBL] [Abstract][Full Text] [Related]
24. NOD2 receptors in adenopituitary folliculostellate cells: expression and function.
Correa-de-Santana E; Fröhlich B; Labeur M; Páez-Pereda M; Theodoropoulou M; Monteserin JL; Renner U; Stalla GK
J Endocrinol; 2009 Oct; 203(1):111-22. PubMed ID: 19608614
[TBL] [Abstract][Full Text] [Related]
25. NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.
Lin Z; Hegarty JP; John G; Berg A; Wang Z; Sehgal R; Pastor DM; Wang Y; Harris LR; Poritz LS; Schreiber S; Koltun WA
Dig Dis Sci; 2013 Sep; 58(9):2599-607. PubMed ID: 23709157
[TBL] [Abstract][Full Text] [Related]
26. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.
Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608
[TBL] [Abstract][Full Text] [Related]
27. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
[TBL] [Abstract][Full Text] [Related]
28. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
29. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.
Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G
Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906
[TBL] [Abstract][Full Text] [Related]
30. NLRP1 and NLRP3 inflammasomes are essential for distinct outcomes of decreased cytokines but enhanced bacterial killing upon chronic Nod2 stimulation.
Hedl M; Abraham C
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G583-96. PubMed ID: 23287275
[TBL] [Abstract][Full Text] [Related]
31. NOD2 up-regulates TLR2-mediated IL-23p19 expression via NF-κB subunit c-Rel in Paneth cell-like cells.
Tan G; Liang E; Liao K; Deng F; Zhang W; Chen Y; Xu J; Zhi F
Oncotarget; 2016 Sep; 7(39):63651-63660. PubMed ID: 27563808
[TBL] [Abstract][Full Text] [Related]
32. Supervised Machine Learning Classifies Inflammatory Bowel Disease Patients by Subtype Using Whole Exome Sequencing Data.
Stafford IS; Ashton JJ; Mossotto E; Cheng G; Mark Beattie R; Ennis S
J Crohns Colitis; 2023 Nov; 17(10):1672-1680. PubMed ID: 37205778
[TBL] [Abstract][Full Text] [Related]
33. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
34. Nod2: a key regulator linking microbiota to intestinal mucosal immunity.
Biswas A; Petnicki-Ocwieja T; Kobayashi KS
J Mol Med (Berl); 2012 Jan; 90(1):15-24. PubMed ID: 21861185
[TBL] [Abstract][Full Text] [Related]
35. NOD1 and NOD2 in inflammation, immunity and disease.
Mukherjee T; Hovingh ES; Foerster EG; Abdel-Nour M; Philpott DJ; Girardin SE
Arch Biochem Biophys; 2019 Jul; 670():69-81. PubMed ID: 30578751
[TBL] [Abstract][Full Text] [Related]
36. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
37. Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease.
de Vries HS; Plantinga TS; van Krieken JH; Stienstra R; van Bodegraven AA; Festen EA; Weersma RK; Crusius JB; Linskens RK; Joosten LA; Netea MG; de Jong DJ
PLoS One; 2009 Nov; 4(11):e7818. PubMed ID: 19915667
[TBL] [Abstract][Full Text] [Related]
38. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
[TBL] [Abstract][Full Text] [Related]
39. Expression of TLR2, NOD1, and NOD2 and the NLRP3 Inflammasome in Renal Tubular Epithelial Cells of Male versus Female Mice.
DeWolf SE; Shigeoka AA; Scheinok A; Kasimsetty SG; Welch AK; McKay DB
Nephron; 2017; 137(1):68-76. PubMed ID: 28614830
[TBL] [Abstract][Full Text] [Related]
40. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.
Moltzau Anderson J; Lipinski S; Sommer F; Pan WH; Boulard O; Rehman A; Falk-Paulsen M; Stengel ST; Aden K; Häsler R; Bharti R; Künzel S; Baines JF; Chamaillard M; Rosenstiel P
Cell Mol Gastroenterol Hepatol; 2020; 10(2):365-389. PubMed ID: 32289499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
